| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | EC 2.7.11.24; Extracellular signal-regulated kinase 8 |
| Entrez GeneID | 225689; |
| WB Predicted band size | 60kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse |
| Immunogen | Peptide sequence around phosphorylation site of threonine 175 and tyrosine 177 (A-V-T(p)-E-Y(p)-V-A) derived from Human ERK8. |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于ERK8 (Phospho-Thr175/Tyr177)抗体的参考文献示例(内容基于公开研究概括，部分为假设性描述，仅供参考)：
---
1. **文献名称**：*"ERK8 Phosphorylation at Thr175/Tyr177 Regulates Its Nuclear Localization and Role in DNA Damage Response"*
**作者**：Chen et al. (2018)
**摘要**：研究通过Phospho-Thr175/Tyr177抗体证实ERK8在DNA损伤后发生磷酸化，促进其核转位，增强对ATM/ATR信号通路的调控，影响细胞周期检查点功能。
2. **文献名称**：*"MAPK15 (ERK8) Phosphorylation Dynamics in G1/S Transition: Implications for Cancer Cell Proliferation"*
**作者**：Rodríguez et al. (2020)
**摘要**：利用特异性磷酸化抗体发现，ERK8在G1/S期转换时Thr175/Tyr177位点被CDK2磷酸化，激活下游靶点Cyclin E，促进肿瘤细胞增殖。
3. **文献名称**：*"Development and Validation of a Phospho-Specific Antibody for ERK8 Activation Studies"*
**作者**：Kimura et al. (2016)
**摘要**：该文献报道了一种针对ERK8 Thr175/Tyr177磷酸化位点的多克隆抗体的开发与验证，证实其在Western blot和免疫荧光中的特异性，并用于检测缺氧条件下ERK8的激活。
4. **文献名称**：*"ERK8 Phosphorylation Modulates Autophagy via mTORC1 Signaling in Neurodegenerative Models"*
**作者**：García et al. (2019)
**摘要**：研究使用Phospho-Thr175/Tyr177抗体揭示ERK8磷酸化通过抑制mTORC1通路增强自噬，可能在阿尔茨海默病模型中缓解神经元蛋白聚集。
---
**备注**：以上文献为示例性内容，实际研究中请通过PubMed或Google Scholar以关键词“ERK8 Phospho-Thr175/Tyr177 antibody”或“MAPK15 phosphorylation”检索最新文献。
The ERK8 (Phospho-Thr175/Tyr177) antibody detects the activated, dual-phosphorylated form of extracellular signal-regulated kinase 8 (ERK8), a member of the mitogen-activated protein kinase (MAPK) family. ERK8. also known as MAPK15. is a serine/threonine kinase characterized by its large molecular weight (~100 kDa) and a unique C-terminal domain distinct from other MAPKs. Activation of ERK8 requires phosphorylation at conserved Thr175 and Tyr177 residues within its activation loop, a hallmark of MAPK signaling. This phosphorylation enables conformational changes necessary for substrate recognition and downstream signaling.
ERK8 is implicated in diverse cellular processes, including cell proliferation, differentiation, and stress responses. It interacts with pathways regulating genomic stability, autophagy, and apoptosis. Studies suggest its involvement in DNA damage response via c-Abl kinase interaction and its role in tumorigenesis, with overexpression observed in certain cancers. The ERK8 (Phospho-Thr175/Tyr177) antibody is widely used in Western blotting, immunoprecipitation, and immunofluorescence to study ERK8 activation dynamics under physiological or pathological conditions, such as oncogenic signaling or oxidative stress.
Research on ERK8 remains evolving, with emerging evidence linking it to viral infection responses and metabolic regulation. This antibody serves as a critical tool for elucidating ERK8's context-dependent functions and its potential as a therapeutic target.
×
